Clinical Trials Browser

Withdrawn × INDUSTRY × blinatumomab × Clear all

NCT00538096 2008-09-05

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Phase 1 Withdrawn

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00676871 2008-09-05

A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell